Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC24072 LY-2584702 free base Featured LY2584702 is a potent, selective, ATP-competitive inhibitor of P70 S6 kinase-1 (p70S6K1) with IC50 of 4 nM.
DC24073 LY-2584702 hydrochloride Featured LY2584702 is a potent, selective, ATP-competitive inhibitor of P70S6 kinase-1 (p70S6K1) with IC50 of 4 nM.
DC7943 LYS6K2(LY2584702) tosylate salt Featured LY-2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.
DC7103 LY2603618(IC-83) Featured LY2603618(IC-83) is a potent and selective small molecule inhibitor of Chk1 protein kinase activity in vitro (IC50=7 nM) and the first selective Chk1 inhibitor to enter clinical cancer trials.
DC7993 Prexasertib (LY2606368) 2HCl Featured LY2606368 2Hcl is a potent and selective ATP competitive inhibitor(IC50=1.5 nM in SW1990 cell) of the Chk1 protein kinase.
DC10796 Prexasertib (LY2606368) Featured LY2606368 is a potent and selective ATP competitive inhibitor(IC50=1.5 nM in SW1990 cell) of the Chk1 protein kinase.
DC7458 LY2608204 Featured LY2608204 is a activator of glucokinase (GK) with EC50 of 42 nM.
DC22140 LY2623091 LY2623091 (LY-2623091) is an orally administered mineralocorticoid receptor antagonist for the treatment of essential hypertension and chronic kidney disease..
DC23444 LY2624803 LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia..
DC7665 Gandotinib(LY2784544) Featured LY2784544 is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2V617F, 8- and 20-fold selective versus JAK1 and JAK3. Phase 2.
DC23510 LY2794193 Featured LY2794193 is a highly potent and selective mGlu3 receptor agonist with Ki of 0.93 nM and EC50 of 47 nM, >100-fold selectivity over mGlu2 receptor..
DC10815 LY2795050 Featured LY2795050 is a novel selective κ-opioid Receptor (KOR) antagonist (IC50=0.72 nM) and has the potential as a PET tracer to image KOR in vivo.
DC7035 Merestinib(LY2801653 dihydrochloride) Featured LY2801653 2HCl is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase(Ki= 2 nM).
DC8586 LY2801653 Featured LY2801653 is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase(Ki= 2 nM).
DC5180 LY2811376 Featured LY2811376 is the first orally available non-peptidicβ-secretase(BACE1) inhibitor with IC50 of 239 nM-249 nM.
DC12081 LY2828360 Featured LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB2) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling.
DC8643 LY2835219 free base (Abemaciclib) Featured LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.
DC5062 LY2835219(Abemaciclib) Featured LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.
DC22595 LY2857785 LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
DC7019 LY-2874455 Featured LY2874455 is a novel and potent FGF/FGFR inhibitor.
DC5053 LY2886721 Featured LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
DC11681 LY2922470 LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM.
DC1058 LY294002 Featured LY294002 is a PI3K inhibitor for p110α, p110δ and p110β with IC50 of 0.5 μM, 0.57 μM and 0.97 μM, respectively.
DC22312 LY2940094 Featured LY2940094 is a potent and selective nociceptin receptor antagonist which inhibits excessive feeding behavior in rodents.
DC7191 LY-2940680(Taladegib) Featured LY2940680 binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling.
DC10833 LY2955303 Featured LY2955303 is a potent and selective RAR-gamma antagonist for the treatment of osteoarthritis pain.
DC21340 LY 2979165 LY2979165 (MP-101) is the alanine prodrug of LY2812223, a selective orthosteric mGlu2 receptor agonist.
DC23688 LY-3000328 Featured LY 3000328 is a potent and selective Cathepsin S (Cat S) inhibitor with IC50s of 7.7 and 1.67 nM for hCat S and mCat S, respectively.
DC8344 LY3009120 Featured LY3009120 is a potent and selective pan-RAF inhibitor with potential anticancer activity.
DC10219 LY3023414 Featured LY3023414 is an oral ATP competitive inhibitor of the class I PI3K isoforms, mTOR and DNA-PK.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X